Teva reaches settlement with Texas over opioid lawsuit
Israeli drugmaker reaches settlement worth $225 million to resolve claims it fueled an opioid epidemic in Texas.
Tags
Teva
News and updates about Teva
Teva investigated in Europe for hindering access to medicine
Israeli drug-maker investigated by over whether it illegally hindered rivals’ access to its multiple sclerosis medicine.
Teva in talks to produce COVID vaccines
Teva chief says company in talks with COVID-19 vaccine makers to co-produce some shots.
EU fines Teva for colluding to delay a cheap sleep disorder drug
European Commission says Teva was in breach of rules after it effectively agreed with another company to keep a cheaper drug off the market.
US accuses Israeli pharmaceutical giant of fixing drug prices
US Justice Department charges Teva of illegally fixing drug prices between 2013 and 2015.
Teva will receive $50m from former directors for bribery fines
Former Teva executives will pay shareholders $50 million in compensation for fines the co. was forced to pay for bribery charges.
Teva CEO to Netanyahu: We will help dismissed employees
Head of struggling pharmaceutical giant refuses to budge after government demands Jerusalem factories remain open, offers to train employees
Teva employees threaten to blow up factory
'Our factory is a ticking time bomb' say employees of pharmaceutical giant Teva. 'We have access to explosives and poison - so be prepared.'
Israel grinds to a halt in strike over Teva layoffs
Large part of Israeli services to grind to a halt as general strike aims at stopping pharmaceutical giant Teva from firing 1,700 workers.
Riots outside Teva's Jerusalem factory over mass layoffs
Employees burn tires, block roads as pharmaceutical giant seeks to cut 14,000 jobs.
PM to CEO of drug giant: Minimize harm to workers
Netanyahu speaks with CEO of Teva Pharmaceutical Industries, amidst company's reported intention to cut thousands of workers in Israel.
Histadrut calls strike over Teva cuts
Histadrut to hold nationwide strike on Sunday following reports that troubled drug giant will cut thousands of jobs.
Israeli drug giant to cut thousands of jobs
Teva Pharmaceuticals reportedly to unveil program cutting over 4,000 jobs, mainly in Israel and the US.
Pharmaceutical giant to lay off thousands worldwide
Teva lays off thousands of workers, closes six factories, after losing $6 billion.
Teva to lay off 350 employees in Israel
Teva to lay off some of its 7,000 employees in Israel it reorganizes.
Teva expected to name new CEO
Teva Pharmaceutical expected to name Pascal Soriot as its next CEO, reports say.
Teva CEO steps down
Erez Vigodman, CEO of Israeli generic drugmaker, resigns amid the company's recent stumbles.
Teva fined $519 million in U.S. for foreign bribes
Israeli generic drug giant Teva will pay $519 million to settle charges that it paid bribes to foreign officials to win business.
Teva to market, distribute medical cannabis inhaler in Israel
Teva Pharmaceutical Industries to become the first major medical company to market and distribute a cannabis inhaler.
Teva completes acquisition of Allergan
Teva Pharmaceutical completes $40 billion acquisition of the generics arm of rival Allergan.
Teva's $40.5 Billion deal to go through next week
Israeli pharmaceutical company wins regulatory approval for acquisition of Allergan, conditional upon giving up some of its products.
Israel graduating from startups to tech giant
Experts disagree as to whether the tech world in Israel is capable of maturing to the level where a tech giant such as Google can exist.
Israeli Pharma Giant Teva Buys Botox's Allergan
$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.
Subsidiary's Crime Costs Teva $1.2 Billion
Israeli pharma giant to pay for illegal monopoly 'pay for delay' move made by company Cephalon - before Teva acquired it.
Shimon Peres to Advise Teva Pharmaceuticals
Consulting job to the tune of $10,000 per month reportedly on the table; details have not been finalized.
Israeli Pharma Teva Looks to Become Global Giant
$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?
Pharmaceutical Giant Teva's Chairman to Resign
Chairman Phillip Frost's announcement the latest in a string of abrupt changes in major Israeli company.
Teva Setback: Competitors Can Sell Copaxone
A U.S. Supreme Court Justice gave a green light for competitors of Teva to sell generic versions of multiple sclerosis drug Copaxone.
Erez Vigodman Named New Teva CEO
Teva on Thursday named Erez Vigodman, 54, as new CEO of the company, after last October's controversial resignation of Dr. Jeremy Levin.
Pfizer Settles with Teva on Generic Viagra
Teva will pay Pfizer a royalty for a license to produce its generic version, from late 2017.
Teva Brings 'Captive Profits' Home, Gets Tax Break
Teva said Monday that it would return tens billions of shekels to Israel from abroad, and pay a tax bill of nearly three billion shekels.
CEO of Teva Pharmaceuticals Steps Down
Jeremy Levin resigns from the pharmaceutical giant amid tensions in the company
Teva: Layoffs Will be Coordinated with Histadrut
After meeting with Histadrut chairman, pharmaceutical giant promises it will coordinate layoff plans.
Lapid 'Dissatisfied' with Teva Layoffs
Finance Minister says he has spoken to Teva's CEO and asked him to reduce the number of employees the company lays off.
Teva Laying Off 5,000 Employees
Pharmaceutical firm will reduce global manpower by 10%; 700-800 layoffs expected in Israel.
American Jew to Head Teva
American Jew Dr. Jeremy Levin was named new CEO for Teva Pharmaceuticals Monday, when Shlomo Yanai announced he is stepping down.
Former CEO of Teva Pharmaceuticals Dies at 79
Eli Hurvitz, who served as CEO of Teva Pharmaceutical Industries until 2002, passes away from a serious illness.
Israeli Drug: No More Insulin Injections?
Two Israeli-based firms try out a peptide aimed at stopping Type 1 diabetes at its source and eliminate the need for insulin injections.
New Lymphoma Cure Passes Phase 2
A new treatment for lymphoma, a type of cancer, has passed its Phase II clinical trial. CT-011 is produced by CureTech, a Teva company.
Teva Appeals Whopping US Verdict
Israel’s Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, has dedicated its new, $100 million distribution center.
Previous
Next